MACKENZIE ALEXANDER R, Executive Vice President, sold 15,000 shares of the Pfizer Inc. (NYSE:PFE) in an exchange that happened on April 1st. The stock was sold at an average price of $42.83 per share, amounting to a transaction worth $642,503. The sale was made public in a document filed with the SEC. Additionally, Executive Vice President JOHNSON RADY A sold 8,700 shares of this stock in a transaction that took place on March 15th. The stock was sold at an average price of $41.13 per share, for a total exchange amounting to $357,831. After the transaction, the Executive Vice President JOHNSON RADY A currently holds 59,797 shares of the company’s stock, which is worth approximately $2494133.
With this stock price’s latest movement, it is now -10.24% away from its 1-year high and 21.36% higher than its 1-year low price. In the past seven days, the stock price volatility for Pfizer Inc. was 1.26%, whereas its volatility in the past 30 days has been 1.31%. This public company’s stock also has a beta score of 0.73. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
Pfizer Inc. (NYSE:PFE) most recently published its quarterly earnings results. The firm posted $0.64 earnings per share (EPS) for the three-month period, surpassing analysts’ consensus estimate of $0.63 by $0.01. The publicly-traded organization reported revenue of $13,976.00 million for the quarter, compared to the average analyst forecast calling for $13,898.80 million, which was surpassing the analyst consensus estimate.
Shares of Pfizer Inc. (PFE) plunged -1.32%, amounting to a loss of -$0.56 per share, to finish the regular trading session at $41.71 on Friday April 12th, 2019. After beginning the session at $42.34, shares of Pfizer Inc. reached as high as $42.34 during the day, while hitting a 1-day low of $41.58. Trade volume reached 20,240,211 shares against this stock’s average daily volume of 24.25M shares, with a total float of 5.55B. As a consequence of the price decrease, Pfizer Inc. now has a current market value of 241.54B.
Tesla, Inc. (NASDAQ:TSLA) subtracted -0.27% to its trading price by the close of the most recent session, dropping from its previous closing price of $268.42 to $267.70. This stock decreased in value by -2.64% during the last 7-day period, and experienced a loss of -7.68% over the past 30-day period. In the past three months, this stock’s price lost by -22.91% , and added 4.21% to its price during the last six months of trading. TSLA demonstrated a yearly price loss of -8.97% , while its year-to-date (YTD) price performance has been down -19.56% . This stock’s price changed by +5.20% compared to its 90-day low, and moved down -23.95% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the TSLA stock as “Sell”. In the short-term, Tesla, Inc. (TSLA) has a 20-day average volume of 9,051,405 shares and short-term indicators sets the TSLA stock as “ 80% Sell ” on average basis. In the medium-term, TSLA stock has a 50-Day average volume of 8,811,564 shares and medium-term indicators gave the average rating of “ 75% Sell ”, while in the long-term period the stock has a 100-Day average volume of 8,236,844 shares. On average, long-term indicators rated the stock as “100% Sell ”. The overall picture from all short, medium and long-term indicators sets the TSLA stock as “88% Sell ” on average basis.
Recently, multiple brokerages have sent out reports on TSLA. ROTH Capital, for example, Reiterated its rating on shares of Tesla, Inc. to a “Neutral”, while setting a $240 price target on shares of the company’s stock, according to a research note from Thursday April 11th, 2019. Nomura Initiated their target price for this stock to $300, while giving the stock a “Neutral” rating, as stated in a research report from Wednesday, April 10th, 2019. Canaccord Genuity, on the other hand, Reiterated a “Buy” rating on this stock, while posting a $391 price target on shares of this company’s stock in a research note dated Thursday, April 4th, 2019.
In other news related to Tesla, Inc. stock, 62.93% shares of TSLA held by institutions. The total number of institutions who held the TSLA shares was 1,070, according to most recent SEC filling. During the past quarter, total 108,699,393 shares held by institutions with the net change of -12,137 shares. In the meantime, 12 new institutions bought the shares of Tesla, Inc. for the first time and 11 institutions sold all their holdings in the company’s common stock. 52 institutions increased their investment in the TSLA stock and 36 institutions decreased their investment in the Tesla, Inc. (TSLA)’s stock during the last quarter.